Define Financial’s AbbVie ABBV Stock Holding History

Define Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$237K	Buy	+907	New	+$233K	0.1%	49

Other funds holding ABBV

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Define Financial's ABBV Position: Q3 2026 in Review

Define Financial opened a new position in AbbVie (ABBV) in Q3 2026: 907 shares worth $237K. The stake represents 0.1% of the portfolio and ranks #49 among its holdings.

780 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Define Financial held 907 shares of AbbVie worth $237K as of Q3 2026.
AbbVie was a new Define Financial position in Q3 2026.
AbbVie made up 0.1% of Define Financial's portfolio in Q3 2026, its #49 holding.
780 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Define Financial's 13F filing for Q3 2026, filed 14 Oct 2026.